Related Experiment Video
Updated: Jun 12, 2026
02:28
Measuring Psoriasis Severity at Home
Published on: March 1, 2024
[Psoriatic arthritis and etanercept]
1Servicio de Dermatología, Hospital Clínico San Carlos, Madrid, España. javierpedraz@aedv.es
Actas Dermo-Sifiliograficas
|May 25, 2010
Summary
Psoriatic arthritis (PA) is a chronic inflammatory disease. This review focuses on etanercept, a biologic treatment, for managing PA effectively.
Area of Science:
- Rheumatology
- Immunology
Background:
- Psoriatic arthritis (PA) is a chronic inflammatory condition often following skin psoriasis.
- Early diagnosis and treatment are crucial to prevent severe joint damage.
Observation:
- Traditional treatments include NSAIDs, DMARDs (e.g., methotrexate), and leflunomide.
- Biologic therapies, particularly anti-TNF drugs, have emerged due to advances in understanding PA pathophysiology.
Findings:
- Etanercept, infliximab, and adalimumab are commonly used anti-TNF agents for PA.
- This systematic review specifically examines the available studies on etanercept for PA treatment.
Implications:
- Understanding etanercept's efficacy is vital for optimizing psoriatic arthritis management.
- This review provides insights into biologic treatment options for patients with psoriatic arthritis.
Related Concept Videos
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
01:29Autoimmune Disorders
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Concept and Mechanism of Autoimmune Diseases
The immune system...